Laboratory Total Liab Over Time
| LH Stock | USD 241.16 0.99 0.41% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Laboratory Performance and Laboratory Correlation. Laboratory |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 2.88 | Earnings Share 5.28 | Revenue Per Share 151.028 | Quarterly Revenue Growth 0.074 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Liab Analysis
Compare Laboratory and related stocks such as Quest Diagnostics, Waters, and Universal Health Services Total Liab Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DGX | 856.3 M | 5.6 B | 5.1 B | 5 B | 5.5 B | 5.2 B | 5.4 B | 5.5 B | 5.7 B | 7.1 B | 7.1 B | 7 B | 6.8 B | 7.6 B | 4.6 B |
| WAT | 235.5 M | 1.5 B | 1.7 B | 1.8 B | 2 B | 2.2 B | 2.4 B | 3.1 B | 2.2 B | 2.8 B | 2.6 B | 2.7 B | 2.8 B | 3.5 B | 3.7 B |
| UHS | 485.8 M | 5.1 B | 5.2 B | 4.8 B | 4.9 B | 5.1 B | 5.7 B | 5.7 B | 5.8 B | 6.1 B | 7.1 B | 6.9 B | 7.5 B | 7.8 B | 8.2 B |
| HOLX | 5.3 M | 7.5 B | 7.1 B | 6.4 B | 5.6 B | 5.2 B | 5.2 B | 4.8 B | 4.3 B | 4.5 B | 4.7 B | 4.2 B | 4.1 B | 4 B | 2.5 B |
Laboratory and related stocks such as Quest Diagnostics, Waters, and Universal Health Services Total Liab description
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.My Equities
My Current Equities and Potential Positions
| Laboratory of | LH |
| Classification | Healthcare |
| Location | North Carolina; U.S.A |
| Exchange | New York Stock Exchange |
USD 241.16
Check out Laboratory Performance and Laboratory Correlation. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Laboratory technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.